DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • United States
  • /
  • Healthcare
Author Program NEWCreate Narrative
ELV logo

Elevance Health, Inc. Stock Price

NYSE:ELV Community·US$90.8b Market Cap
  • 4 Narratives written by author
  • 0 Comments on narratives written by author
  • 230 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

ELV Share Price Performance

US$418.72
111.81 (36.43%)
​
US$390.54
Fair Value
US$418.72
111.81 (36.43%)
7.2% overvalued intrinsic discount
US$390.54
Fair Value
Price US$418.72
NateF US$390.54
AnalystConsensusTarget US$449.10
AnalystLowTarget US$393.00
Wed, 4 Feb 26
Fair ValueUS$390.54
Share Pricen/a

ELV Community Narratives

NA
NateF's
Fair Value
·
Fair Value US$390.54 7.2% overvalued intrinsic discount

ELV Market Outlook

2users have liked this narrative
0users have commented on this narrative
11users have followed this narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value US$449.1 6.8% undervalued intrinsic discount

ELV: Margin Recovery Will Drive Upside Despite ACA Headwinds And Premium Increases

0users have liked this narrative
0users have commented on this narrative
111users have followed this narrative
AN
AnalystLowTarget
AnalystLowTarget's
Fair Value
·
Fair Value US$393 6.5% overvalued intrinsic discount

ACA And Medicaid Will Squeeze Margins Though Tech Will Aid

0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
ELV logo
Elevance Health
7.2% overvalued intrinsic discount

ELV Market Outlook

View narrative
NA
NateF
Updated 5 Jan 2025
Read Narrative
ELV logo
Elevance Health
6.8% undervalued intrinsic discount

ELV: Margin Recovery Will Drive Upside Despite ACA Headwinds And Premium Increases

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 28 Jul
Read Narrative
ELV logo
Elevance Health
6.5% overvalued intrinsic discount

ACA And Medicaid Will Squeeze Margins Though Tech Will Aid

View narrative
AN
AnalystLowTarget
AnalystLowTarget
Updated 11 Aug
Read Narrative
ELV logo
Elevance Health
15.9% undervalued intrinsic discount

Aging Trends And Digital Integration Will Expand Managed Care Markets

View narrative
AN
AnalystHighTarget
AnalystHighTarget
Updated 16 Jun
Read Narrative

Trending Discussion

No trending discussion available.

Recently Updated Narratives

NA
ELV logo

ELV Market Outlook

Fair Value: US$390.54 7.2% overvalued intrinsic discount
11 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystLowTarget
ELV logo

ELV: Medicaid Pressures And Cancer Care Initiatives Will Shape 2026 Earnings Visibility

Fair Value: US$393 6.5% overvalued intrinsic discount
4 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystConsensusTarget
ELV logo

ELV: Medicaid Discipline And Exits Will Set Up Future Margin Recovery

Fair Value: US$449.1 6.8% undervalued intrinsic discount
111 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative

Snowflake Analysis

Undervalued with excellent balance sheet and pays a dividend.

0 Risks
4 Rewards
View Full Analysis

Elevance Health, Inc. Key Details

US$201.1b

Revenue

US$148.8b

Cost of Revenue

US$52.3b

Gross Profit

US$47.3b

Other Expenses

US$5.0b

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
22.88
25.99%
2.47%
69.0%
View Full Analysis

About ELV

Founded
2001
Employees
96615
CEO
Gail Boudreaux
WebsiteView website
www.elevancehealth.com

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.

Recent ELV News & Updates

User avatar
Narrative Update • Aug 11

ELV: Medicaid Pressures And Cancer Care Initiatives Will Shape 2026 Earnings Visibility

Analysts have raised their fair value estimate for Elevance Health to $393 from $331, reflecting updated expectations for slightly higher profit margins, a modestly higher future P/E, and ongoing discussion of Medicaid cost pressures and state exits following recent Q2 results and price target changes across the Street. Analyst Commentary Street research on Elevance Health over the past few months has been active, with many firms updating price targets and ratings around Q1 and Q2 results, Medicaid developments, and broader views on managed care.

Recent updates

No updates

Elevance Health, Inc. Competitors

UNH logo

UnitedHealth Group

Symbol: NYSE:UNH
Market cap: US$340.3b
ABT logo

Abbott Laboratories

Symbol: NYSE:ABT
Market cap: US$176.4b
ISRG logo

Intuitive Surgical

Symbol: NasdaqGS:ISRG
Market cap: US$130.4b
CVS logo

CVS Health

Symbol: NYSE:CVS
Market cap: US$121.1b
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide